Posts by vgn1
Omicron: Transmissibility, Immune Evasion, and Pathogenicity
Omicron: Transmissibility, Immune Evasion, and Pathogenicity January 13, 2022 We are currently in a wave of SARS-CoV-2 infections dominated by the recently discovered omicron variant. What new threats does it pose? It is clearly able to overcome immune barriers to infection. Also, this variant is far more transmissible than others, making it an hyper transmissible…
Read MoreDeltacron: a new variant or a laboratory contamination?
Deltacron: a new variant or a laboratory contamination? Scientists have recently reported the emergence of new SARS-CoV-2 variant, “Deltacron”, resulting from the recombination of Omicron and Delta variants in infected patients. According to a GVN scientist, Deltacron is not a new variant, but the result of laboratory contamination. His sequence analysis suggests that the Omicron…
Read MoreGVN and Monaco COVID-19 Diagnostic Conference: Executive Summary
A December 2-3, 2021 Conference Towards the Deployment of a Global and Collaborative Diagnostic Arsenal to Detect and Fight Against Pandemics Amid global spread of the Omicron variant, under the High Patronage of H.S.H. Prince Albert II of Monaco, the Global Virus Network(GVN), the Centre Scientifique de Monaco, the Fondation Prince Albert II de Monaco,…
Read MoreGVN and Monaco COVID-19 Diagnostic Conference: Promises and Challenges
GVN and Monaco COVID-19 Diagnostic Conference: Promises and Challenges Thursday, December 02, 2021 – Friday, December 03, 2021 Towards the deployment of a global and collaborative diagnostic arsenal to detect and fight against pandemics November 30, 2021: The current COVID-19 pandemic, and in particular the proliferation of variants such as Omicron, again emphasize the importance of…
Read MoreGlobal Spread of Omicron, New Variant of Concern
Global Spread of Omicron, New Variant of Concern November 29, 2021 The first known confirmed Omicron (B.1.1.529) infection was from a specimen collected on November 9, 2021. The variant quickly became a new variant of concern because of its rapid spread in South Africa and globally, as well as the large number of mutations found…
Read MoreAvian Influenza Viruses
Avian Influenza Viruses November 26, 2021 The global death toll from COVID-19 reached 5 million on November 1, 2021, but the actual figures are likely much higher (1). In recent history, the 1918 H1N1 flu pandemic caused by an Influenza A (H1N1) virus was the most severe known pandemic, killing more than 50 million people worldwide (2). The sequence analysis…
Read MoreLong COVID: The Impact of Post-Acute Sequelae of COVID-19 (PASC)
November 12, 2021 There is mounting evidence of the importance and seriousness of the long-term effects of COVID-19. Post-acute sequelae of SARS-CoV-2 (PASC, or “long COVID”) is characterized by persistent symptoms and/or delayed or long-term complications beyond 4 weeks from the onset of symptoms (1). Approximately 80% of individuals with a confirmed COVID-19 diagnosis continue to…
Read MoreGVN and Monaco COVID-19 Diagnostic Conference: Promises and Challenges
GVN and Monaco COVID-19 Diagnostic Conference: Promises and Challenges Thursday, December 02, 2021 – Friday, December 03, 2021 Towards the deployment of a global and collaborative diagnostic arsenal to detect and fight against pandemics The current COVID-19 pandemic has again emphasized the importance of accurate, rapid, and massively deployed diagnostics to effectively contain viral transmission.…
Read MoreNew Antivirals: Could They Be Game Changers?
November 1, 2021 There have been recent reports of potentially effective oral antiviral drugs, including RNA replicase and viral protease inhibitors. If these prove safe and effective, this may overhaul the care of patients with COVID-19 by preventing severe COVID-19 in infected patients and, possibly in the future, prevent infection after contamination. It is likely…
Read MoreNew Antivirals: Could They Be Game Changers?
New Antivirals: Could They Be Game Changers? November 1, 2021 There have been recent reports of potentially effective oral antiviral drugs, including RNA replicase and viral protease inhibitors. If these prove safe and effective, this may overhaul the care of patients with COVID-19 by preventing severe COVID-19 in infected patients and, possibly in the future,…
Read More